Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer

被引：3
|
作者：
Lupo, A. [1 ,2 ,3 ,4 ]
Alifano, M. [2 ,5 ]
Wislez, M. [1 ,2 ,3 ,4 ,6 ]
Boulle, G. [1 ,2 ,3 ]
Velut, Y. [1 ,2 ,3 ]
Biton, J. [7 ]
Cremer, I. [1 ,2 ,3 ]
Goldwasser, F. [2 ,8 ]
Leroy, K. [2 ,9 ]
Damotte, D. [1 ,2 ,3 ,4 ]
机构：
[1] INSERM, UMRS 1138, Equipe Canc Immune Control & Escape, Ctr Rech Cordeliers, Paris, France
[2] Univ Paris 05, F-75006 Paris, France
[3] Univ Pierre & Marie Curie Paris, F-75005 Paris, France
[4] Hop Cochin, AP HP, Serv Pathol, F-75014 Paris, France
[5] Hop Cochin, AP HP, Serv Chirurg Thorac, F-75014 Paris, France
[6] Hop Tenon, AP HP, Serv Pneumol, F-75014 Paris, France
[7] Univ Paris 13, Sorbonne Paris Cite, Lab Immunol & Immunopathol Li2P, Inserm UMR 1125,Physiopathol Cibles & Therapies P, F-93000 Bobigny, France
[8] Hop Cochin, AP HP, Serv Oncol Med, F-75014 Paris, France
[9] Hop Cochin, AP HP, Serv Genet & Biol Mol, F-75014 Paris, France
来源：
REVUE DE PNEUMOLOGIE CLINIQUE | 2018年 / 74卷 / 05期
关键词：
Lung cancer; Biomarkers; Immune checkpoint inhibitors; Immunotherapy; PULMONARY SQUAMOUS-CELL; PD-1; BLOCKADE; ANTI-PD-L1; ANTIBODY; CLINICAL-RESPONSE; CTLA-4; OPEN-LABEL; EXPRESSION; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; MULTICENTER;
D O I：
10.1016/j.pneumo.2018.09.010
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Immune checkpoint inhibitors (ICI), targeting the PD1/PD-L1 axis has shown their efficacy in lung cancer but only in a restricted population of patients, thus it is mandatory to identify biomarkers predicting the clinical benefit. In this article we will describe and analyzed biomarkers already published, from protein, to RNA and at last DNA markers, discussing each markers feasibility and interest. In the future, combined analysis of several markers will probably be proposed, particularly with the increasing complexity of therapy schema with molecules association. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：339 / 350
页数：12
相关论文
共 50 条
  • [41] Challenges of PD-L1 testing in non-small cell lung cancer and beyond
    Wang, Minyu
    Wang, Sen
    Trapani, Joseph A.
    Neeson, Paul J.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4541 - 4548
  • [42] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    LABORATORY INVESTIGATION, 2018, 98 : 133 - 133
  • [43] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [44] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [45] Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
    Heigener, David F.
    Reck, Martin
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1468 - S1473
  • [46] PD-L1 Expression and Molecular Alterations in Non-Small Cell Lung Cancer
    Ebare, K.
    Song, W.
    Opitz, L.
    Rosca, O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S52 - S53
  • [47] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [48] EFFICACY OF PD1/PD-L1 INHIBITORS VS CHEMOTHERAPY AS FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER AMONG PATIENTS WITH DIFFERENT PD-L1 EXPRESSION LEVELS
    Lin, G.
    Lingohr-Smith, M.
    Deitelzweig, C.
    Lin, J.
    VALUE IN HEALTH, 2022, 25 (07) : S318 - S318
  • [49] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [50] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    MODERN PATHOLOGY, 2018, 31 : 133 - 133
12345